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We have used elements of the E. coli lactose (lac) 
operon to produce a collection of herpes simplex virus 
types 1 and 2 glycoprotein D (gD-l and gD-2) antigens. 
Our approach employed recombinant DNA techniques 
to construct plasmids with various segments of the gD-
1 and gD-2 coding sequences fused to the lacZ gene. 
Such hybrid genes were expressed in a regulated man­
ner in E. coli by joining them to the lac promoter­
operator region. Efficient translation of these hybrid 
genes was facilitated by incorporating a coding sequence 
specifying a short peptide leader (>.cro) in the plasmid 
expression vectors resulting in synthesis of chimeric 
Cro-gD-�-galactosidase proteins. In addition, insertion 
of synthetic translation terminators at the junction of 
gD and lacZ enabled us to produce specific truncated gD 
polypeptide sequences unfused to tJ-galactosidase. 
The gD antigens produced in E. coli were not glyco­
sylated and were generally recovered as dense insoluble 
aggregates. Proteins containing portions of gD-I or gD-
2 were analyzed by immunoprecipitation using anti­
HSV rabbit serum and a number of monoclonal antibod­
ies recognizing different epitopes of gD-l. Initial animal 
studies were done with antigens that reacted with neu­
tralizing antisera or monoclonal antibodies. When these 
bacterially produced proteins were injected into rabbits, 
antibodies were produced that specifically immunopre­
cipitated authentic gD polypeptides and neutralized the 
infectivity of both virus types. These studies suggest 
that gene fusion techniques can be used to produce im­
munogenic proteins in large quantity. These polypep­
tides are not only useful in analyses of gene structure 
and function, but also can provide novel diagnostic re­
agents and well-defined pure antigens for vaccine de­
velopment. 
The general use of purified proteins from important viruses 
of medical sign ificance for diagnostic reagents, experimental 
tools, and subunit vaccines has been slowed or made impossible 
because samples of sufficient quantity, high purity, reproducible 
quality, and defined structure were difficult to obtain. Advances 
in modern biology have made the picture much more sanguine_ 
For example, chemical synthesis of peptides provides a source 
of antigens of defined and predetermined structure [ 1 ] .  I n  
addition , t h e  u s e  of monoclonal antibodies facilitates identifi­
cation of specific protein segments and makes possible high­
level purification of polypeptides [2]. F inally , recombinant 
DNA technology simplifies the analysis of viral gene structure 
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and function and also makes possible the inexpensive commer· 
cial production of many important proteins. It is a particular 
use of this latter technology, the construction of protein fusions, 
that is the subject of this report. 
The lactose (lac) operon of E. coli has played a central role 
in molecular biology [3] .  It represents one of the best under­
stood biological regulatory systems and has provided E. coli 
molecular biologists with an enviable set of reagents. Until 
recently, the general use of this knowledge and material was 
severely limited. However, with the recognition of translocat­
able elements and the advent of recombinant DNA technology, 
it is now possible to fuse virtually any gene, regardless of its 
function, to the control region of the lac operon (operon fusion) 
or to the first gene of the operon, lacZ (protein fusion) [4]. 
Consequently, many of the phenotypes of lac, so well and 
carefully detailed in the past 30 years, can be conferred to any 
gene. 
In this report, we will demonstrate the use of fusions to 
elements of the lac operon in the analysis of the glycoprotein 
D genes of herpes simplex virus types 1 and 2. Our purpose is 
twofold: first, to demonstrate some of the potential of gene 
fusion technology and E. coli molecular biology for production 
and analysis of herpes simplex antigens, and second, to docu· 
ment our progress to date on production of defined antigens 
for potential use in prophylaxis and therapy of herpes simplex 
virus infections. 
MATERIALS AND METHODS 
Techniques 
Bacterial strains, plasmids, and specific recombinant DNA methods 
are as described previously [5-7]. General principles and methods for 
work with gene fusions in E. coli are presented in Silhavy et al. [8]. 
The lac Operon 
The lac operon of E. coli contains three genes, the first two of which 
encode proteins required for growth on lactose. The first gene of the 
operon is the lacZ gene specifying the enzyme {:i-galactosidase, which 
hydrolyzes the disaccharide lactose into glucose and galactose. The 
second gene of the operon is the lacY gene specifying a membrane­
bound permease that actively transports lactose and its analogues into 
the cell. The operon is negatively controlled at the level of transcription 
by a repressor, the product of the lacI gene . The repressor can be 
inactivated by the addition of lactose or its analogues. 
The laeZ gene product (the enzyme {:i-galactosidase} is one of the 
largest and most genetically malleable proteins in E. coli. The enzyme 
is a tetramer of four identical subunits, each with a molecular weight 
of 1 16,000 [9] . This unusually stable enzyme can withstand boiling for 
10 minutes with retention of 30% activity and survives extensive 
trypsin digestion with almost no loss of activity. The peptide backbone 
is sensitive to these treatments, but the many disulfide bridges and 
noncovalent interactions hold the enzyme in a highly stable confor­
mation [ 10]. The amino-terminal portion of each subunit is involved 
in tetramerization, and the carboxy-terminal portion functions in hy­
drolysis of i1-galactosides [4]. An important feature of i1-galactosidase 
essential for its use in protein fus ion technology is that almost any 
amino acid sequence can be substituted for the authentic amino· 
terminal sequences without destroying enzyme activity [11] . However, 
no more than 26 amino acids of the authentic amino terminals can be 
removed from i1-galactosidase without permanent loss of enzymatic 
activity[ 4]. This rather phenomenal property enables one to fuse por-
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tions of, or entire genes, to lacZ and still retain {:I-galactosidase activity 
in the hybrid protein. The enzyme activity can be simply assessed in 
colonies using indicator media such as lactose-MacConkey agar or 
lactose-tetrazolium agar. Other indicator media and chromogenic sub­
strates have been described [4,12]. 
Protein Fusion Expression Vectors 
There are two basic strategies for expression of foreign genes in E. 
coli. In one, a bacterial transcription control sequence is fused to a 
foreign gene. Translation of the gene is effected by proper positioning 
of the natural initiation codon (or a synthetic codon if the first few 
amino acids are not appropriate) and natural or synthetic ribosome­
binding sequences. The protein produced is exact, or nearly so, with 
respect to primary structure of the original foreign protein. In practice, 
pJS413 
6485 bp 
FIG 1. Structure of the plasmid expression vector pJS413 (not 
drawn to scale). Open boxes indicate the relative positions of coding 
sequences specifying the Cro leader (cro), the lael/Z fusion, and {:I­
lactamase (which confers ampicillin resistance upon bacteria trans­
formed with the plasmid). The cro and lael/Z sequences are transcribed 
clockwise under the transcriptional control of the lac promoter-operator 
lIac pia). The poly linker sequence contains three unique restriction 
sites (BgllI-SrnaI-BamHI) at which DNA sequences to be expressed 
can be cloned. Translation of fusion proteins initiates at ATG and 
terminates at TAA. The origin of replication (ori) is required to initiate 
plasmid DNA synthesis in E. coli. 
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FIG 2. Genome location and restric-
tion maps of the gD-l and gD-2 struc-
tural genes. The top line represents the 
HSV genome, which consists of two -== 
unique DNA segments (UL and Us) each 
gO-1 � C) �Iilll flanked by inverted repetitions (TRd il I-IRL and TRs/IRs). The coding sequences < IE! I of gO-1 and gD-2 are indicated by boxes. ! The solid portion of the box indicates gO-2 J_� the signal peptide sequence and the di- �I 51�1�1 agonally hatched box indicates the 
transmembrane region. 
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these exact-expression systems are sometimes inefficient in expression 
because of messenger RNA instability, protein instability, or poor 
translation. In the second strategy for expression of foreign genes, a 
particular gene segment is joined to or inserted within a bacterial gene 
such that a hybrid protein is produced. This novel protein consists of 
a foreign polypeptide covalently coupled to the bacterial protein. Such 
fusion protein genes are often expressed as efficiently as the original 
bacterial gene. The fusion protein strategy has utility in expressing 
many defined segments of foreign genes without the technical problems 
of constructing exact expression systems for each gene segment. 
We have used a versatile protein fusion expression vector called 
pJS413[7] (Fig 1). The vector contains hybrid coding sequences into 
which foreign coding sequences can be inserted for the generation of 
fusion proteins. The hybrid coding sequences are transcribed from a 
derivative of the lac promoter called UV5. This promoter is not subject 
to catabolite repression. 
Transcription is negatively controlled by the lac repressor (product 
of the lael gene). In the presence of repressor, the hybrid gene is not 
transcribed unless induced by lactose or {:i-galactoside analogues such 
as isopropyl-li-D-thiogalactoside (lPTG). The first 68 base pairs of the 
hybrid coding sequences are derived from the amino terminal of the 
bacteriophage A era gene. This short leader sequence is fused to a 
hybrid fl'-galactosidase gene (a short region from the 3' end of the lael 
gene fused to the lacl, gene ) via a synthetic polylinker sequence con­
tain ing a series of restriction-enzyme cleavage sites. Translation initi­
ates using the ribosome-binding site of ero, an efficient translation 
signal. The ero leader is specifically out of translation phase with the 
lacI/Z gene due to the polylinker. Thus no active Cro-{:i-galactosidase 
enzyme can be made from this gene. However, insertion of a coding 
region (for example , gD) at one of the cloning sites in the poly linker 
allows one to phase correctly the em leader and the lacI/l, gene. If the 
inserted coding sequence is in the correct translational reading frame 
with the ero leader and the lacl/l, gene, translation will result in a 
tripart ite protein, Cro-gD-(1 gal, having functional iJ'-galactosidase ac­
tivity. B acterial colonies synthesizing this hybrid protein can easily be 
scored as Lac+ on indicator plates. 
Fusion proteins made in this way are formally analagous to synthetic 
peptides coupled to protein carriers: gD peptides are "coupled" to the 
{:I-galactosidase carrier as a result of gene fusions_ Specific fusions to 
{:I-galactosidase or Cro can be made at the sites within the gD coding 
sequence to produce genes of defined truncation. Similarly, internal 
deletions or site-directed mutagenesis can alter specific regions or sites 
by design. In this way, a collection of antigens can be prepared in 
quantity with defined primary structure and reproducible quality. 
RESULTS 
The Glycoprotein D Genes of HSV-J and HSV-2 
Herpes simplex types 1 and 2 virions contain at least four 
glycoproteins in their respective viral envelopes [13). The struc­
ture and function of these polypeptides and their genes are of 
interest because they are involved in absorption, viral morpho­
genesis, and cell-to-cell interaction and probably are the pri­
mary contacts with the host immune system [14,15). We have 
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begun our studies with the gD polypeptides because several 
lines of evidence indicate that gD is the major immunogen of 
the virus and is found in the cell membranes in abundance 
after infection [14,16). 
The structural genes of gD-l and gD-2  are in essentially the 
same location in the genome [17]. It has been established that 
while each polypeptide has a number of distinct antigenic 
determinants, certain epitopes are shared in common [14). We 
have subsequently characterized the gD-1 mRNA and have 
completely sequenced both the gD-1 and gD-2  structural genes 
[5,18,19). These analyses proved that both gD genes are closely 
related and that there are no introns within either gD coding 
sequence. The lack of introns facilitated our work with lac gene 
fusions because it allowed us to work directly with genomic 
DNA rather than with a cDNA copy. 
The location and restriction maps of the gD- 1  and gD-2 
coding regions are shown in Fig 2. Analysis of the DNA se­
quence indicated that the gD-1 coding region could encode a 
protein of 394 amino acids and that of gD-2  one of 393 amino 
acids. By examination and comparison of the deduced amino 
acid sequences, it was obvious that both proteins shared the 
general structure of a typical membrane glycoprotein. The key 
features included a signal peptide sequence, a large main body, 
a transmembrane sequence, and a charged anchor sequence. 
For ease of analysis, we divided the protein sequences into three 
parts: the signal peptide sequence, the main body, and the 
transmembrane-anchor region. The signal peptide sequences 
are removed during maturation of gD- 1  and gD-2,  presumably 
during passage of the glycoprotein through a membrane. By 
comparing the deduced amino acid sequences of gD-1 and gD-
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FIG 3. Sequence and hydrophilicity plots of gD-l and gD-2 signal 
peptides. Amino acid sequences of the signal peptides are given using 
the single-letter code. Where the gD-1 and gD-2 residues are identical, 
a dot represents the gD-2 amino acid. The relative hydrophilicity index 
(y axis) is plotted against the residue number as deduced from the 
DNA sequence (x axis). The y-axis values indicate the relative water 
affinity of amino acid side chains and are calculated using values 
derived from the work of Wolfenden et al. [27] and S. Kent (unpub­
lished). Calculations and plotting were done using a computer program 
package designed by S. Kent, J. L'Italien, and D. Anderson (in prepa­
ration). Positive numbers (above the line) indicate increasing hydro­
philicity, while negative numbers (below the line) indicate increasing 
hydrophobicity. This plot is a running-number average of the relative 
hydrophilicity index taken over 7 amino acids. Consequently, the first 
point on the graph is plotted at position 4 (the average hydrophilicity 
of residues 1-7); the second point is the average hydrophilicity of 
residues 2-8; the last point is the average hydrophilicity of residues 22-
28. Open circles represent gD-1 and closed circles represent gD-2 values. 
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2 with the amino-terminal sequences of the mature proteins 
(RJ Eisenberg, D Long, R Hogue-Angelotti, GH Cohen, per· 
sonal communication) ,  it was found that both signal peptides 
are 25 amino acids in length. The mature forms of both glyco· 
proteins begin with the lysine at position 26 of the deduced 
sequences. A comparison of the signal peptide sequences is 
presented in Fig 3. The signal peptides represent the most 
divergent portion of the amino acid sequences, with 15 of 25 
residues mismatched. It is noteworthy, however, that a plot of 
the local hydrophilicity indicated that the general hydrophobic 
character of both peptides remains highly conserved (Fig 3). 
Such conservation most probably reflects similar requirements 
for each signal peptide in membrane transport and processing. 
The second region of the gD glycoproteins is the main body. 
A direct comparison of the amino acid sequences of these 
regions from gD- l  and gD-2 is presented in Fig 4. This segment 
begins with amino acid 26 of the deduced sequence (the first 
amino acid of the mature sequence) and ends with a sequence 
defined by a hydrophobic alpha-helical region predicted in both 
gD-l and gD-2  that begins 55 residues from the carboxy ter · 
minal. This hydrophobic region probably represents the por· 
tions of each polypeptide that span the lipid bilayer. If this 
general structure is correct, then 314 amino acids of gD·! 
(residues 26-339) and 313 amino acids of gD-2 ( residues 26-
338) would be located external to the viral envelope. These 
external segments, therefore, are likely to be the only portions 
of either gD polypeptide accessible to the immune system and 
involved in cell-virus or infected-cell interactions. In contrast 
to the signal peptides, the external-body sequences are highly 
conserved. There are only 37 residue changes out of 314, plus 
one amino acid deletion, in gD-2 . There are several common 
features that bear special note. First, both polypeptides have 
three predicted glycosylation sites in precisely the same loca· 
tion .  The predicted N-linked glycosylation sites (asparagine· 
X-serine or asparagine-X-threonine) are indicated by branched 
structures in Fig 4. Second, both polypeptides have six cysteine 
residues,  expected to be involved in specific folding through 
disulfide linkages, located in the same positions (filled circles 
below the line in Fig 4) . Finally, both polypeptides contain an 
abundance of proline residues. The main body of gD-1 contains 
39 and that of gD-2 contains 37 .  These residues impose major 
structural constraints on protein conformation. It is significant, 
therefore, that the position of 33 of the 39 proline residues in 
gD-1 is conserved in gD-2  (boxed residues in Fig 4) . 
The third region of both glycoproteins to be considered is 
the transmembrane-anchor region defined by the carboxy-ter· 
minal 55 amino acids. The comparison of the deduced amino 
acid sequences is given in Fig 5. The first 25 residues represent 
the protein portion predicted to span the lipid bilayer, and the 
last 30 amino acids represent the highly charged portion that 
presumably functions to anchor each glycoprotein to the memo 
brane. Like the signal peptide sequence, this region is more 
variable in sequence than the main body. In the 55 residues 
shown, the gD -2  sequence differs from the gD-1 sequences in 
17 positions. Nevertheless, the local hydrophilicity of both 
peptides is remarkably similar (Fig 5 ) .  The hydrophobic nature 
of the putative transmembrane region is in marked contrast to 
the highly charged and hydrophilic nature of the terminal 
anchor sequence. 
Construction of Expression Plasmids Containing gD Sequences 
We have used the expression vector pJS413 to construct 
plasmids that specify two types of' gD-related proteins in E, 
coli. In one type of plasmid, exemplified by pEH25, the pJS413 
cro leader sequence was ligated with gD coding sequences so 
that they were in the same translational reading frame (Fig 6, 
A). The hybrid coding sequences initiated at the era ATG 
codon and terminated at the gD TAG codon. Such hybrid genes 
were placed under the transcriptional control of the pJS413lac 
promoter-operator. The construction of pEH25 resulted in 
deletion of gD-1 DNA encoding 52 amino-terminal amino acids 
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FIG 4. Comparison of the extra membrane amino acid sequences of mature gD-l and gD-2. Amino acids are represented using the single-letter 
code. Where the gD-2 amino acid is identical to that of gD-l, it is represented by a dash. Numbers represent amino acid positions in the deduced 
sequence. The three potential asparagine-linked glycosylation sites are represented by branched side chains. Proline residues are enclosed by 
boxes and cysteine residues are indicated by closed circles below the residue. The position in the gD-l sequence where there is no equivalent gD-
2 amino acid is indicated by an arrow. 
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(Fig 6, C). The sequence deleted included the entire 25 amino 
acid signal peptide coding region. In other constructions 
(pEH51 and pEH71; Fig 6, C), fewer amino-terminal coding 
sequences of gD-l were deleted. Plasmid pEH51 contains gD-l 
DNA encoding all but the initial 6 amino acids of the signal 
peptide, whereas pEH71 encodes a Cro-gD-l protein including 
all but 32 amino-terminal residues of gD-l. As the signal 
peptide sequence is proteolytic ally removed in maturation of 
gD-l, pEH71 contains all but 7 amino-terminal residues of 
mature gD-l. 
In the other type of expression plasmid, exemplified by 
360 370 380 390 394 
pEH4-2, the cro-gD sequences contained by the plasmids de­
scribed above were ligated to the lacljZ gene of pJS413 to form 
a continuous cro-gD-lacljZ coding sequence (Fig 6, B). In the 
construction of pEH4-2, the carboxy-terminal gD-l coding 
sequences of pEH25 were removed by digestion with Bal31 
exonuclease. DNA fragments having between 40 and 240 bp of 
gD-l sequences deleted were isolated by preparative agarose gel 
electrophoresis. Ligation of these DNA fragments to a pJS413 
backbone generated a population of plasmids containing vari­
ably deleted gD-l DNA fused to the amino-terminal lacljZ 
coding sequence. Since there are three potential translational 
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reading frames, only one in three of these plasmids would be 
expected to have the correct cro-gD-lacl/Z reading frame. 
Therefore, E. coli containing this plasmid population were 
screened by replica-plating on lactose-MacConkey agar plates. 
Cells transformed with plasmids specifying a Cro-gD-j3-gal 
protein were red on these indicator plates because such chimeric 
proteins retain j3-galactosidase activity. A number of  plasmids 
specifying chimeric proteins were selected in this way. These 
include the gD-l containing plasmids pEH4-2, pEH4-1, 
pEH90-5, and pEH90-10. As shown in Fig 6, C, these plasmids 
contain the same Cro-gD-l fusion as pEH25, but differ in the 
amount of carboxy-terminal gD-l sequences deleted. The gD-l 
sequences deleted in pEH4-2 include the entire transmem­
brane-anchor coding region, whereas pEH4-1 specifies a protein 
containing the transmembrane sequence and 7 amino acids of  
the anchor sequence. 
Plasmids specifying Cro -gD-l-j3-gal proteins containing ad­
ditional amino-terminal gD-l sequences were constructed as 
follows: Plasmids pEH81 and pEH82 were generated by ligating 
DNA fragments containing the amino-terminal coding region 
ofpEH51 to a fragment containing the carboxy-terminal coding 
sequence of pEH4 - 1  and pEH4-2, respectively. Likewise, 
pEH83 and pEH84 were constructed by ligation of a pEH71 
DNA fragment with pEH4-1 and pEH4-2 DNA fragments. In 
this way, we have made a battery of  plasm ids that specify 
chimeric proteins containing different components of the gD-l 
Vol. 83, No.1 Supplement 
polypeptide (Fig 6, C).  In addition, we have constructed a 
plasmid, pHV -6, that specifies a chimeric protein containing 
gD-2 sequences (Fig 6, C).  We will describe below the applica· 
bility of these various plasmid expression systems to produce 
antigens of defined specificity in E. coli. 
Expression of gD Sequences in E. coli 
The Cro-gD-1  and Cro-gD-1 -j3-gal proteins specified by 
pEH25 and pEH4-2, respectively, were examined using anti­
bodies directed against authentic virus-encoded gD- l  to assess 
the immunologic integrity of the bacterially produced polypep· 
tides. We have previously reported that rabbit anti-HSV·l 
serum and a number of monoclonal antibodies directed against 
gD-l immunoprecipitate both the pEH25 and pEH4-2 proteins 
[5,6]. As shown in Fig 7, both proteins react with rabbit anti· 
HSV - 1  serum in a Western blot analysis. Duplicate 1 -ml 
cultures of both pEH25 and pEH4-2 transformants were grown 
to late logarithmic phase; then one culture of each was induced 
by adding IPTG to 1 mM. After incubation for a further 1 h at 
3TC, the bacteria were pelleted by centrifugation and resus· 
pended in sample buffer. The samples were boiled and the 
proteins resolved by SDS-polyacrylamide gel electrophoresis 
( SDS-PAGE).  Following electrophoresis, the proteins were 
transferred electrophoretically to nitrocellulose. Proteins 
bound to the membrane were reacted successively with either 
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FIG 7. Western blot analyses of proteins specified by pEH25 and 
pEH4-2. Duplicate cultures of pEH4-2 and pEH25 transformants were 
grown to late logarithmic phase and then grown either in the presence 
(+) or absence (- ) of IPTG for 1 h. Proteins from the equivalent of 0.1 
ml of culture were resolved by 8D8-PAGE and transferred to nitrocel­
lulose. Proteins immobilized on the membrane were first reacted with 
either the anti-gD-l 558 monoclonal (20) or with rabbit anti-HSV-l 
serum (obtained from DAKO). Antibodies bound to the blot were 
detected by reaction with 125I-labeled rabbit anti-mouse IgG antibodies 
or 125I-labeled goat anti-rabbit IgG antibodies followed by autoradiog­
raphy. Indicated are the positions of molecular weight standards run 
in parallel and the locations of the pEH4-2 Cro-gD-iJ-gal and pEH25 
ero-gD proteins. 
rabbit anti-H8V-l serum or the 558 monoclonal antibody and 
then mI-labeled goat anti-rabbit IgG or rabbit anti-mouse IgG 
antibodies. Reaction of these antibodies to the pEH25 and 
pEH4-2 proteins was visualized by autoradiography of the 
nitrocellulose sheet. It was apparent from this experiment (Fig 
7) that small amounts of these proteins were made in the 
absence of the lac inducer, IPTG. Significantly greater amounts 
were synthesized in its presence,  however. It is noteworthy that 
the 55S monoclonal antibody [20] reacted with the Cro-gD-1 
protein specified by pEH25, but did not react with the pEH4-
2 Cro-gD-l -iJ-gal protein (Fig 7). The gD-l sequences of pEH4-
2 differ from those of pEH25 in that the carboxy-terminal 69 
amino acids are deleted as a result of the fusion to iJ-galacto­
sidase. This result, therefore, indicates that the 55S epitope 
lies in the carboxy-terminal region of gD-l .  In support of this 
interpretation, we have found that synthetic peptides compris­
ing the carboxy-terminal 33 peptides of gD- 1  react with the 
55S monoclonal antibody in an ELISA assay (results not 
shown). 
It appeared in the Western blot analysis that the pEH25 and 
pEH4-2 proteins were present in approximately equimolar 
amounts following the l -h  induction period. The similar inten­
sity of the bands observed, however, more probably reflects the 
reactivity in the Western blot procedure of gD-l carboxy-
BACTERIAL EXPRESSION OF HSV gD 1078 
terminal sequences unique to the pEH25 protein, since we have 
consistently observed little accumulation of the Cro-gD-1 pro­
tein in this induction period, whereas the Cro-gD-l-iJ-gal pro­
tein represented a significant percentage of the total E. coli cell 
protein (approximately 2-4 % ). Indeed, we have observed that 
the carboxy-terminal gD-l sequences contained by pEH25 are 
deleterious for expression of this foreign protein in E. coli [7]. 
A further demonstration of those gD-! sequences affecting the 
level of accumulation of Cro-gD - l -iJ-gal proteins in E. coli is 
described below. 
The gD-1 DNA sequences contained by plasmids pEH4-2 
and pEH4- l and their derivatives pEH81, pEH82, pEH83, and 
pEH84 are described above (see also Fig 6, C).  Overnight 
plasmid-containing cultures were diluted 1/20 to duplicate 
tubes of 1 ml of L broth. One of each pair of cultures was 
induced with IPTG (1 mM final concentration), and both 
cultures were then incubated at 37'C for 6 h.  The cells were 
collected by centrifugation and lysed by boiling in sample 
buffer, and the proteins were resolved by SDS-PAGE. Coom­
assie blue staining of the gel (Fig 8) revealed that pEH4-2, 
pEH84, and pEH82 made large quantities of Cro-gD-1-iJ-gal 
(approximately 10% of the total cell protein) upon IPTG in­
duction. This result indicated that the signal peptide sequences 
contained by pEH82 and the additional amino-terminal coding 
sequences contained by pEH84 had no effect on the level of 
accumulation of these Cro-gD- 1 -iJ-gal proteins. In contrast, 
very little of the pEH4-1,  pEH83, and pEH81 proteins were 
found to accumulate even with IPTG induction (Fig 8). This 
result again demonstrated that the additional carboxy-terminal 
gD- 1  sequences present in each of these plasmids, which include 
the transmembrane sequences and seven amino acids of the 
anchor sequence, are deleterious for expression in E. coli. It is 
noteworthy that IPTG induction of these latter cultures had 
an adverse effect on cell growth,  resulting in decreased amounts 
of all E. coli polypeptides. The deleterious effect of carboxy­
terminal gD- 1 sequences on accumulation of Cro-gD-1 -iJ-gal 
proteins may be explained, at least in part, by the toxic nature 
of this amino acid sequence. 
We previously observed that accumulation of the pEH4-2 
Cro-gD-1-iJ-gal protein in E. coli resulted in, or perhaps was 
dependent on, the formation of dense, insoluble aggregates in 
the cytoplasm of the cell. The formation of aggregates seems 
to be a general property of iJ-galactosidase fusion proteins 
[21]. We have demonstrated that the Cro-gD- 1 -iJ-gal protein 
specified by pHV6 also forms these aggregates. As shown in 
Fig 9, this protein comprises a significant proportion of the 
total cell protein in IPTG-induced cells transformed with 
pHV6. Disruption of induced cells with lysozyme and nonionic 
detergent treatment followed by separation of particulate ma­
terial from soluble material by pelleting through a sucrose pad 
resulted in almost exclusive partition of the fusion protein in 
the pellet fraction (Fig 9). The property of aggregation makes 
it possible to obtain a reasonable purification of the iJ-gal fusion 
protein in one step simply by disruption of cells and centrifu­
gation. Higher levels of purification may be obtained by resus­
pending the pellet by sonication and pelleting again . 
We have reported previously on the immunogenic properties 
of pEH4-2 and pHV6 chimeric proteins in rabbits [6,7]. These 
proteins were prepared as immunogens by separating aggregate­
purified polypeptides by SDS-PAGE, excision of the appropri­
ate gel slice, and maceration. Rabbits were inoculated subcu­
taneously several times in all with 100-200 Ilg of the fusion 
protein emulsified in complete Freund's adjuvant. Antibodies 
were raised that recognized the cognate virus-encoded glyco­
protein in various immunologic assays. Antibodies raised 
against the pEH4-2 protein immunoprecipitated both gO-1 and 
gD-2 and also neutralized in vitro the infectivity of both HSV­
l and HSV-2. Antibodies raised against the pHV6 protein 
likewise neutralized both HSV-1 and HSV-2 infectivity [7]. 
While all anti-pHV6 protein  sera immunoprecipitated gD-2, 
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FIG 8. Influence of the transmem· 
brane anchor sequence on expression of 
chimeric proteins. E. coli NF1829 cui· 
tures containing plasm ids pEH4-2. 
pEH4-1. pEH81, pEH82, pEH83, and 
pEH84 were grown in the absence (-) or 
presence (+) of IPTG. Proteins were 
analyzed by SOS-PAGE and Coomassie 
Blue staining. Indicated are the position� 
of molecular weight markers run in par­
allel and of the chimeric Cro-gO-l-iJ-gal 
proteins. 
only certain sera immunoprecipitated the heterologous gD-j 
[ 7 ] .  Using these immunogens, it was generally observed that 
the resultant antisera had a higher neutralizing titer against 
the homologous virus type, indicating that these chimeric pro­
teins contain both type-specific and type-common antigen ic 
determinants. 
Preparation of Immunogens Unfu.�ed to tJ-galactosidase 
Although we have demonstrated the immunogenicity of gD­
containing tJ-galactosidase fusion proteins in rabbits, the prob­
ability existed that fusion proteins may not be acceptable for 
use as immunogens in humans. We have devised a general 
scheme, therefore, to make Cro-gD proteins unfused to p­
galactosidase in high yields in E. coli. To do so, it was necessary 
to both delete the toxic carboxy-terminal sequences of gD-j 
and to protect the resultant truncated Cro-gD-l protein against 
the very active proteolytic system of E. coli. These goals were 
conveniently achieved by expressing a truncated Cro-gD-1 pro­
tein in concert with a Cro-gD-l-tJ-gal protein as described 
below. 
Plasm ids having in-phase fusions of cro-gD-1 sequences with 
the lacl/Z gene were made using the vector pHK414. This 
vector is identical to pJS413 except that it has a polylinker 
containing the restriction sites BglII-HindIII-SmaI-BamHI 
between the cro and lacl/Z segments (Fig 1 and Fig 10, A). In 
construction of these plasmids, Bal31-randomized carboxy-ter· 
minal gD-l DNA was ligated to the filled in BglII terminal of 
pHK4l4, resulting in a set of plasmids (the pEH90 series) 
containing the sites HindIII-SmaI-BamHI at the gD-1-tl-gal 
junction (Fig 1 0, B). E. coli strain NF1829 was transformed 
with the pEH90 series and plated on rich medium with no 
lactose. The resulting colonies were screened by replica plating 
to lactose-MacConkey agar plates and p icking the red Lac· 
colonies. The gD-l carboxy-terminal e nd points in plasm ids 
obtained from these transformants were determined by DNA 
sequencing. Here we will report on studies with the isolates 
pEH90-5 and pEH90-1O (Fig 6, C). These plasmids have the 
same cro-gD-1 fusion point as pEH4-2. Plasmid pEH90-5 has 
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a deletion of 44 carboxy-terminal gD- 1  codons (and hence 
encodes 1 1  amino acids of the transmembrane sequence) ,  
whereas pEH90-10  specifies a protein deleted for 73 carboxy­
terminal gD- 1  amino acids. 
The presence of HindlII and BamHI restriction sites at the 
gD-1 : lacl/Z junction in plasmids pEH90-5 and pEH90-10 pro­
vided a convenient way to precisely insert at the junction a 
synthetic DNA sequence with cohesive Hindl II and BamHI 
terminals. As shown in Fig 10,  C, this particular synthetic DNA 
sequence contains a termination codon (TAG, amber) . The 
linker sequence was designed to retain the translational phasing 
of the cro-gD - l  and lacl/Z sequences and to terminate trans­
lation of the gD- 1  coding sequence with the amber codon. E. 
coli strain NF1829 transformed with plasmids containing this 
amber linker (pEH90-5am and pEH90- 10am) had a pink colony 
phenotype on lactose-MacConkey indicator agar in contrast to 
the red colony phenotype of their progenitors. This is consistent 
with our expectation that these plasmids would specify trun­
cated Cro -gD proteins and not {:i-gal fusion proteins. 
The final step to create a high-level expression system for 
this truncated Cro-gD polypeptide was to transfer the amber 
codon containing plasmids into a strain encoding an amber 
suppressor tRNA. The particular strain chosen was LE392,  
which contains two amber suppressor genes (supE and supF) .  
The mutant tRNAs specified b y  these genes will insert gluta­
mine (supE) or tyrosine (supF) in the growing polypeptide 
chains at positions specified by the amber termination codon. 
These suppressor tRNAs, therefore, allow translational read­
through of the synthetic termination codon.  However, suppres­
sion or read-through is significantly less than 1 00 % .  The effi­
ciency of supE suppression has been estimated at 14% and that 
of supF at 55% [22] .  We predicted, therefore, that expression of 
pEH90-5am and pEH9-lOam in E. coli LE392 should result in 
a mixture of Cro-gD - l  truncated protein (from termination at 
the amber codon) and Cro-gD - 1 -{:i-gal (from read-through of 
the amber codon and termination at the {3-gal terminator 
codons (see Fig 10, D ) .  This prediction was tested as follows. 
Overnight 1 - ml cultures of E. coli NF1829 transformed with 
pEH90-5,  pEH90-1O,  pEH90-5am, and pEH90-lOam and E. 
coli LE392 transformed with pEH90-5am and pEH90-10am 
were used to inoculate 50 ml of L broth. IPTG was added to 1 
mM and the cultures were incubated at 37°C for 7 h. The cells 
were collected by centrifugation and lysed with lysozyme fol­
lowed by nonionic detergent treatment. The soluble proteins 
were separated from protein aggregates by centrifugation, and 
equivalent amounts of each supernatant and pellet fraction 
were analyzed by SDS-PAGE. Coomassie Blue staining of the 
gel (Fig 1 1 )  indicated that the pEH90-5 and pEH90-10  Cro­
gD- 1 -[:i-gal proteins were present in the pellet fraction only, as 
expected. In E. coli NF1829 cells transformed with pEH90-5am 
and pEH90- lOam, the Cro-gD-1 -{3-gal protein was not observed 
in either the supernatant or pellet fractions, indicating that 
there was no sign ificant read-through of the amber codon. In 
contrast, in E. coli LE392 transformed with these plasmids, 
large amounts of this chimeric protein were made, indicating 
that the amber codon was being translated as predicted. In 
addition, in E. coli LE392, but not in E. coli NF1829, proteins 
of sizes consistent with those predicted of the truncated Cro­
gD- 1  polypeptides were present in the pellet fraction only (Fig 
11 ) .  As expected, the putative Cro-gD-1  protein specified by 
pEH90-5am was larger than that specified by pEH90- lOam. 
We have confirmed that these proteins are authentic Cro-gD-
1 polypeptides by  Western blot analysis [7] . 
The experiment described above demonstrated that gD- 1 -
related proteins unfused to {3-galactosidase can b e  produced in 
a stable form in E. coli. We have found that such truncated 
amber fragments are unstable when synthesized in E. coli 
NF1829 and are stabilized by synthesizing the {:i-galactosidase 
fusion protein in concert .  The truncated Cro -gD - l  proteins in 
E. coli LE392 may be partially purified by virtue of their 
property of aggregation. These proteins often constitute as 
much as 3% of the total cell protein. Their potential use as 
immunogens has been studied as follows.  
Aggregate-forming proteins were prepared from E. coli LE392 
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transformed with pEH90 - 1 0am and were separated by SDS­
PAGE. The gel slice containing the Cro-gD - 1  protein was 
excised, macerated, and emulsified in complete Freund's adju­
vant.  Two rabbits ( R327 and R328) were inoculated with 200 
f,lg of protein at days 1 ,  28, 42 ,  and 56.  Serum was collected 
from these animals at days 0,  34, 48, 62, and 69 and used to 
immunoprecipitate authentic gD - 1  radio labeled in HSV- 1 in­
fected Vero cells. We found that  high titers of immunoprecipi­
tating antibody were obtained after four inoculations of the 
antigen ( Fig 1 2 ) .  Even after two inoculations ( at day 34 ) ,  low 
titers of ant ibody were apparent in  R327 serum. These results 
indicate that t he Cro-gD - 1  amber fragments are immunogenic 
in rabbits. The neutralization titers of these sera were found to 
be comparable with those obtained using Cro-gD - 1 -{3-gal pro­
teins as immunogens [6 , 7 ] .  
DISCUSSION 
We have shown here that specific polypeptide sequences of 
HSV -1 and HSV - 2 glycoprotein D can be made in  quantity in 
E. coli. Rabbits inoculated with these antigens produced anti­
bodies that recognized authentic gD - 1  and gD - 2  and that neu­
tralized the infectivity of both HSV - 1 and HSV - 2  in vitro. The 
ability to make defined protein sequences in large quantity 
should facil itate studies of the function of these viral polypep-
tides and should also provide a means to produce antigens of 
high quality and safety for use as diagnostic reagents and 
immunogens.  
The precise function of gD - l  and gD - 2  in the HSV replication 
cycle is unknown. However, the ability of certain monoclonal 
antibodies to gD to neutralize virus infectivity in  the absence 
of complement [ 20 ,33]  indicates a role for this glycoprotein in 
absorption of the virus to cells. Glycoprotein gD appears to be 
involved also in fusion of infected cells, since anti-gD mono­
clonals inhibit this phenomenon [ 24 ] .  The polypeptide se­
quences involved in these properties may be examined by 
raising antibodies to defined regions of the gD structure and 
testing whether such antibodies are able to inhibit these func­
tions.  
The central role of gD in  the infectivity of HSV and the 
ability of this virus to pass from cell to cell ,  by cell fusion, 
without scrutiny by the humoral immune system may indicate 
that gD is a prime target for the eventual prevention and 
therapy of herpes simplex virus disease. The history of vacci­
nation in control of human herpesvirus infections, while quite 
long, is not very distinguished [ 2 5 ] . However, positive indica­
tions of the effectiveness of an HSV vaccine in preventing and 
treating herpes genitalis has recently been obtained by Skinner 
and colleagues [ 2 6 ] . It is our intention to study the effectiveness 
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FIG 12 .  Immunoprecipitation of 
HSV-l  encoded gD- l  by R327 and R328 
sera. Rabbit sera (5 1'\)  collected at days 
9, 34, 48, 62, and 69 was reacted with 
["Sl methionine"labeled proteins ex­
tracted from H SV -1 infected Vero cells. 
Immune complexes were collected by ad­
sorption to Staphylococcus aUreus and 
analyzed by SDS-PAGE and fluorogra­
phy [6l . Indicated are the position of 
precursor (pgD - l )  and mature (gD - l )  
forms of the glycoprotein. 
of biosynthetically produced HSV polypeptide sequences, both 
related to gD and to other HSV glycoproteins, in limiting herpes 
simplex virus disease. Such vaccines, if effective, would offer 
advantages over conventionally prepared vaccines, in that prob­
lems of virus and viral DNA contamination are completely 
obviated. 
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